A cross-linked polymeric micellar delivery system for cisplatin(IV) complex

Eur J Pharm Biopharm. 2013 Jan;83(1):63-75. doi: 10.1016/j.ejpb.2012.09.004. Epub 2012 Oct 6.

Abstract

A polymeric cisplatin(IV) prodrug in the form of cross-linked micelles (M(Pt(IV)) was prepared by first constructing MPEG-b-PCL-b-PLL micelles and then attaching a cisplatin(IV) complex with two axial succinic moieties to the lysine residues of the carrier polymer in aqueous medium. The micelles obtained were characterized by TEM, DLS, and zeta potential measurement. Their in vitro release experiments were carried out at pH 7.4 and 5.0 or in the presence of 5mM sodium ascorbate (NaAsc). Results showed that the micelles were sensitive to both acidic hydrolysis and mild reducing agents; in the presence of 5mM NaAsc, cisplatin(II) was directly released and the released cisplatin(II) could chelate with nucleobases; the micelles displayed comparable cytotoxicities to cisplatin; and the micelles were much more efficiently internalized by the cells than cisplatin(II) and cisplatin(IV) counterparts. Moreover, in vivo study showed accumulation of more Pt species in the tumor site and lower systematic toxicity compared to free cisplatin(II) and cisplatin(IV). This polymeric prodrug of cisplatin is expected to be used more for future study and applications.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / toxicity
  • Cell Line, Tumor
  • Cisplatin / administration & dosage
  • Cisplatin / pharmacology*
  • Cisplatin / toxicity
  • Cross-Linking Reagents / chemistry
  • Drug Carriers / chemistry*
  • Drug Delivery Systems
  • Female
  • Humans
  • Hydrogen-Ion Concentration
  • Mice
  • Mice, Nude
  • Micelles
  • Microscopy, Electron, Transmission
  • Neoplasms / drug therapy
  • Neoplasms / pathology
  • Polyesters / chemistry*
  • Polylysine / chemistry*
  • Prodrugs
  • Uterine Cervical Neoplasms / drug therapy
  • Uterine Cervical Neoplasms / pathology
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents
  • Cross-Linking Reagents
  • Drug Carriers
  • Micelles
  • Polyesters
  • Prodrugs
  • methoxy poly(ethylene glycol)-b-poly(epsilon-caprolactone)-b-poly(L-lysine)
  • Polylysine
  • Cisplatin